Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

Name: Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors
License: Public Domain

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

ClinicalTrials.gov · Datasets · License: Public Domain

solid tumors, peritoneal carcinomatosis, nsclc adenocarcinoma, urothelial carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256876
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.